In human breast cancer cells, knockdown or inactivation of KDM3A abolished the recruitment of estrogen receptor alpha (ERα) to its target gene enhancer/promoter regions, leading to a downregulation of ERα target genes and attenuated response to estrogen-stimulated cell growth [14]. This evidence concerns the gene ESR1 and breast carcinoma.